Board communications in a biotech company are among the most consequential documents the CEO produces. They shape investor and board confidence, inform fiduciary decisions, and create the information foundation on which governance oversight depends. They also require significant time to prepare, organize, and deliver effectively.
The biotech CEO who personally manages every aspect of board communication preparation is consuming hours that should go to scientific strategy, pipeline decisions, investor relationships, and operational leadership. A delegation framework for board communications preserves the CEO’s strategic ownership while distributing the preparation, coordination, and follow-through to capable delegates.
The Components of Biotech Board Communications
Before building a delegation framework, it helps to enumerate what board communications actually involve in a biotech context:
Board meeting preparation encompasses drafting board presentation materials, preparing management reports from each functional area, coordinating the preparation of committee materials (audit, compensation, science, and governance), distributing materials in advance of meetings, and managing board logistics including scheduling and travel for in-person meetings.
Ongoing board communication between meetings includes monthly or quarterly financial and operational updates, communications about material developments such as clinical results, regulatory actions, or strategic decisions, and individual outreach to board members on specific governance or advisory matters.
Investor relations communications to the board include the investor perspective on organizational strategy, market context, and shareholder sentiment that boards expect to receive from CEO leadership.
Each of these communication streams has components that are genuinely CEO-level and components that are delegatable.
Assigning a Chief of Staff or Board Liaison Function
The most effective delegation structure for biotech board communications centers on a Chief of Staff, Corporate Secretary, or dedicated Board Liaison who owns the logistical and coordination infrastructure.
Their responsibilities include:
Maintaining the board meeting calendar and committee meeting schedule. Coordinating the preparation of functional area reports from the CFO, CMO, CSO, and other functional leaders. Assembling board packages in the correct format, with all required materials, delivered on the board’s required timeline. Managing board member communication logistics: meeting notices, information requests, and follow-up from board actions. Maintaining board governance records including minutes, action items, and committee charters.
The CEO provides the strategic narrative that frames board materials, reviews and approves all materials before distribution, and leads the board presentation and discussion. The Chief of Staff or Board Liaison makes the production system work.
For foundational frameworks on pharma and biotech CEO delegation architecture, the pharma CEO delegation guide provides detailed structures adaptable to board communication contexts.
Delegating Functional Area Report Preparation
Board packages in biotech companies typically include reports from multiple functional areas: clinical development progress, regulatory affairs updates, manufacturing and quality reports, commercial or business development updates, and finance. The CEO does not write these reports personally.
Each functional leader is responsible for preparing their area’s contribution to the board package. The Chief of Staff provides a consistent template, a clear deadline, and any guidance from the CEO on what the board needs to understand about that function’s activities in the current period.
The CEO reviews each functional report for accuracy, clarity, and strategic relevance before it goes into the final board package. This review might take 30 to 60 minutes for a full set of reports. Writing the reports from scratch would take significantly longer.
This delegation requires functional leaders to understand what a board-appropriate communication looks like: clear, accurate, appropriately detailed, and connected to strategic implications. If functional leaders have not written board materials before, invest in brief guidance or templates that establish the standard.
The CEO’s Board Presentation Role
The CEO’s primary board communication role is leading the board meeting: presenting the organizational narrative, facilitating strategic discussion, responding to board questions, and ensuring the board has what it needs to discharge its governance responsibilities.
This is a CEO-level function. The preparation for this role, however, can be largely delegated. The Chief of Staff drafts an initial presentation framework. The CEO reviews, restructures, and refines it. The Chief of Staff incorporates the CEO’s changes and produces the final slide deck. The CEO reviews the final version and prepares their talking points.
This collaborative preparation process typically takes 20 to 30 percent of the time that the CEO would spend building the presentation from scratch. And the result is often better, because the Chief of Staff brings a fresh perspective on how the narrative lands for a board audience.
Managing Between-Meeting Board Communications
Board members in biotech companies expect to stay informed between formal meetings, particularly when significant developments occur: clinical readouts, regulatory decisions, partnership announcements, or major financial events. Managing this ongoing communication requires a system.
The Chief of Staff maintains a board communication calendar that tracks what information boards members need to receive and when. Standard communications such as monthly financial summaries are produced by the CFO and distributed by the Chief of Staff on a defined schedule. The CEO reviews and approves these before distribution but does not draft them.
For unscheduled material events, the CEO drafts or reviews a brief communication to the board chair or full board as appropriate. The Chief of Staff manages distribution and ensures that the communication reaches all relevant parties, including legal counsel review when needed.
Coordinating Committee Operations
Biotech boards typically have standing committees: audit, compensation, governance/nominating, and often a science or pipeline committee. Each committee has its own meeting schedule, materials requirements, and relationship with management.
The CEO coordinates with committee chairs at a relationship level. The Chief of Staff or designated functional leads coordinate the operational logistics of each committee: scheduling meetings, preparing agenda materials, ensuring the appropriate management participants are prepared, and maintaining committee minutes and records.
The audit committee relationship is owned by the CFO, who manages the financial reporting, internal controls, and auditor relationship that fall under audit committee oversight. The CEO participates in audit committee meetings but is not the primary management interface.
The science committee relationship is typically owned by the Chief Scientific Officer or Chief Medical Officer, who presents pipeline and scientific progress. The CEO participates but is not the primary science communicator.
According to Harvard Business Review, biotech and life sciences boards that receive well-prepared, structured materials and clear management presentations consistently report higher governance effectiveness than those where board communication is informal or CEO-dependent.
Investor Relations Integration With Board Communications
Biotech CEOs typically have investor relations responsibilities that overlap with board communications. Major institutional investors, healthcare-focused funds, and sell-side analysts form part of the external accountability ecosystem that boards expect management to maintain.
A Head of Investor Relations or IR Manager should own the investor communications function: managing quarterly earnings calls or operational updates, maintaining investor relationships at the analyst and portfolio manager level, coordinating investor day events, and producing investor presentations.
The CEO participates in investor communications at the executive level: leading earnings calls or operational updates, meeting with major shareholders at key relationship moments, and engaging with sell-side analysts on strategic topics. The IR function manages the infrastructure.
The IR function also feeds board communications: providing the CEO with the investor sentiment and market context that the board needs to hear as part of the CEO’s external perspective.
Building the Board Communication Calendar
One of the most useful delegation tools for biotech board communications is a comprehensive board communication calendar built and maintained by the Chief of Staff. This calendar includes:
Board meeting dates and committee meeting dates. Preparation milestones: when functional reports are due, when draft board packages are ready for CEO review, when final packages are distributed. Between-meeting communication cadences: monthly financial summaries, quarterly operational updates. Annual governance events: compensation review cycles, board evaluation processes, director nominations, and auditor assessments.
This calendar keeps the board communication system on track without the CEO needing to personally track every deadline.
See pharma clinical operations for how the clinical reporting dimension of board communications integrates with the broader clinical operations delegation system in biotech.
Conclusion
Board communications are too important to handle poorly and too time-consuming for the CEO to manage operationally. The delegation framework described here places the production, coordination, and logistics of board communication in the hands of capable delegates while preserving the CEO’s strategic role in determining what the board hears, how it is framed, and how it connects to organizational direction.
Invest in a Chief of Staff or Board Liaison who can make this system work. Build the functional report preparation discipline across your leadership team. Create the board communication calendar that keeps everything on track. Then show up to board meetings as the organizational leader, not the administrative coordinator, and use that time to earn and maintain board confidence in your strategic leadership.
Related Reading
For further context, explore Delegation Framework for the 3PL Provider CEO and Delegation Framework for Academic Medical Center CEO.